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Crosslinking-mass spectrometry (XL-MS) serves to identify interaction sites between
proteins. Numerous search engines for crosslink identification exist, but lack of ground truth
samples containing known crosslinks has precluded their systematic validation. Here we
report on XL-MS data arising from measuring synthetic peptide libraries that provide the
unique benefit of knowing which identified crosslinks are true and which are false. The data
are analysed with the most frequently used search engines and the results filtered to an
estimated false discovery rate of 5%. We find that the actual false crosslink identification
rates range from 2.4 to 32%, depending on the analysis strategy employed. Furthermore,
the use of MS-cleavable crosslinkers does not reduce the false discovery rate compared to
non-cleavable crosslinkers. We anticipate that the datasets acquired during this research will
further drive optimisation and development of XL-MS search engines, thereby advancing our
understanding of vital biological interactions.
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Chemical crosslinking combined with mass spectrometry(XL-MS) is frequently used to gain structural informationon proteins and protein complexes1,2. In a crosslinking
experiment, a reagent forms covalent bonds between specific
amino acid side-chains that are in close spatial proximity, thus
revealing distance restraints between residues, and hence inter-
action sites within a protein or between different proteins3,4.
Initial applications of these techniques were limited to small
proteins and protein complexes. More recently, due to major
methodological and technological developments, XL-MS has been
applied to living cells to investigate protein interactions and
topological structures at the proteome-wide level5–8.
For studies on small proteins and protein complexes, standard
crosslinking reagents disuccinimidyl suberate (DSS), bis-(sulfo-
succinimidyl) suberate (BS3), or bis-(sulfosuccinimidyl) glutarate
(BS2G) are typically used which react with lysine residues and N-
termini of proteins, and to a lesser extent with serine, threonine,
and tyrosine. Several complications arise during the identification
of crosslinked peptides with such reagents. Measurement of
the intact mass of the crosslinked moiety, rather than the mass of
the individual peptides, quadratically increases the number
of possible peptide pairings to be searched with the number of
peptides in the database (often referred to as the ‘n-squared’
problem), and is thought to reduce confidence in the assignment of
crosslinked peptides9. With the aim of overcoming this limitation,
MS-cleavable crosslinkers such as disuccinimidyl dibutyric urea
(DSBU) and disuccinimidyl sulfoxide (DSSO) were intro-
duced10,11. This class of reagents contains MS-labile bonds at either
side of a functional group within their spacer regions that can be
selectively and preferentially fragmented prior to peptide backbone
cleavage during collision induced dissociation (CID) or higher-
collision induced dissociation (HCD). Gas-phase cleavage of the
crosslinking reagent during tandem MS enables MS3 acquisition
methods, which facilitate peptide sequencing using traditional
database search engines due to circumvention of the n-squared
problem. Additionally, cleavable crosslinkers generate diagnostic
ion doublets during MS2, which are required for the use of novel
database search engines such as XlinkX and MeroX that provide
means for proteome-wide XL-MS studies12,13.
Another critical challenge during XL-MS lies in estimating the
error rate in a search for crosslinked peptides. In protein iden-
tification by mass spectrometry an FDR (false discovery rate)
method is often used, whereby incorrect decoy sequences added
to the search space correspond with incorrect search results
which might otherwise be deemed correct. This allows the
estimation of how many incorrect results are in a final dataset.
In XL-MS, the FDR estimation is complicated by the fact that
every match is a combination of two peptides, each with its own
probability to be false. Further, false discovery rates can be esti-
mated at different points during data analysis, for example,
protein or residue pairs, and misuse of these approaches can lead
to a higher error in the results than is targeted in the search9.
Owing to the versatility of XL-MS techniques, many algorithms
have been developed to identify crosslinks from mass spectrometry
datasets. For example, algorithms used in conjunction with non-
cleavable, non-labelled crosslinkers include (but are not limited to)
pLink14, StavroX15, Xi16 and Kojak17. For MS-cleavable reagents,
XlinkX12 and MeroX13 are often used. pLink, StavroX, Xi,
MeroX and XlinkX have an inbuilt FDR calculator, whereas Kojak
relies on external tools to estimate FDRs such as Percolator18 or
PeptideProphet19 which is incorporated into the trans proteomic
pipeline20.
Crosslinks are often validated by mapping them onto crystal-
lographic models and measuring the distance between the α-carbon
atoms of the crosslinked residues10,11,21,22. Distances that are within
a defined cut-off point are considered to be true, and those that
exceed this distance limit, and are therefore in disagreement with the
structural model, are regarded as false positives. One limitation of
such methods to test bioinformatic approaches is that the formation
of non-specific crosslinks during the experimental procedure cannot
be fully eliminated, and such a crosslink would wrongly be defined
as a false positive. Furthermore, such an approach often under-
estimates FDR since the crosslinks that are evaluated are limited to
those that are formed between peptides contained in the same
protein model23. This lack of a generally accepted method on
how to control for falsely identified crosslinks may have severe
implications that are far-reaching in biological research.
Several elegant benchmarking approaches were utilised by
Chen et al.24 during the evaluation of pLink 2. Simulated datasets,
synthetic datasets25, 15N metabolically labelled datasets and
entrapment datasets17,26 were used to compare the precision and
sensitivity of pLink 2 compared to other search engines. The
synthetic dataset was obtained by taking 38 synthetic peptides
derived from the sequence of the UTP-B protein and crosslinking
them in one reaction. Data were searched against increasingly
larger databases, and the sensitivity and precision of pLink 1,
pLink 2 and Kojak were reported.
To date, comprehensive assessment of the accuracy and sensi-
tivity of XL-search algorithms have been hindered by a lack of
ground truth data that can be used to determine whether crosslinks
were correctly or incorrectly assigned. To overcome this problem,
we have constructed a synthetic library of up to 426 crosslinked
peptides. This allows the unambiguous discrimination of XL-MS
spectra that are correctly, incorrectly, and not identified across all
search engines developed for the identification of crosslinks from
the MS data. In the following scenarios, results are filtered to an
estimated FDR of 5% at the CSM level, and the actual FDR is
subsequently calculated based on the design of the library. For
search engines with inbuilt validation strategies for error estimation
(pLink, Xi and StavroX), calculated false crosslink identification
ranges from 5.2% to 11.3%. When different validation strategies
(Percolator and PeptideProphet) are applied to the same Kojak
search output, calculated false crosslink identification ranges from
2.4% to 32%. False crosslink identification by MeroX is calculated to
be 4.9% or 8.3% for Rise and Riseup mode, respectively. When
recommended score cut-off values are used for XlinkX, calculated
false identification ranges from 0% (with stepped-HCD MS acqui-
sition strategy) to 6.2% (employing MS2-MS3).
Results
Design of the crosslinked peptide library. The crosslinked pep-
tide library was based on the amino acid sequences of tryptic
peptides from S. pyogenes Cas9 and was chemically synthesised
according to Fig. 1. Ninety-five peptides were selected for synthesis
that were 5–20 residues long, containing a single lysine residue for
crosslinking purposes. To prevent peptide N-termini and C-
terminal lysine residues from crosslinking during formation of the
library, any C-terminal lysine residues were incorporated into the
peptide as epsilon-azido-L-lysine, and the N-terminus of the peptide
was protected from crosslinking with a biotin group covalently
linked to a generic ‘linker’ peptide sequence YGGGGR, followed by
the library peptide sequence (Fig. 1a). Subsequently, the only
crosslinker-reactive site in each peptide at the time of crosslinking
was one single lysine residue. Peptides were crosslinked with the
gradual addition of crosslinking reagent to favour the formation of
crosslinks (as opposed to monolinks that would likely form if all the
XL reagent was added at once). The crosslinked peptides were
then treated with trypsin overnight to enzymatically cleave the
N-terminal biotin-linker peptide region, and subsequently treated
with TCEP to reduce the C-terminal lysine azido-group to an
amine. After trypsin digestion, the most abundant species in the
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solution was the biotin-linker, which strongly interfered with MS
measurements, limiting the amount of material that could be loaded
onto the analytical column. The biotinylated peptide species was
therefore removed with streptavidin beads (Fig. 1b), and the
resulting mixture exclusively comprised of crosslinked and mono-
linked tryptic peptides. Incompletely processed peptides, as well as
peptides crosslinked via serine, threonine and tyrosine residues, did
not feature highly in our results and were therefore not considered
in our analysis.
To create a challenging dataset for the assessment of XL-search
algorithms, the synthetic peptides were divided into 12 groups for
crosslinking, which were then combined prior to analysis via LC-
MS. This theoretically gives rise to 426 potential crosslinks. It can be
inferred that crosslinks identified between two peptides of the same
group can be correct, while those identified between two peptides
from separate groups are known to be false positives (Fig. 1c).
Assessment of search engines for non-cleavable crosslinkers.
The DSS-crosslinked peptide library was measured via LC-MS/MS
and the resulting data were analysed with pLink, StavroX and Xi
(Fig. 2). Figure 2a shows the number of crosslink spectrum
matches (CSMs) identified by the different search algorithms that
correspond to correct (black) and incorrect (grey) crosslinks.
To assess the reproducibility of XL-MS workflows, values are
presented as an average of three technical replicates, and the error
bars represent the standard deviation. For all algorithms, the data
were searched against the sequence of S. pyogenes Cas9 and 10
additional proteins (Supplementary Data 2) and the results were
filtered to an estimated 5% FDR at the CSM level (referred to from
here on as CSM-FDR).
pLink identifies the highest number of correct CSMs (678) and
has a calculated FDR of 4.3%. StavroX and Xi identify a lower
number of correct CSMs (410 and 512 respectively), with lower
calculated FDR values of 2.4% and 2.5% respectively. The Venn
diagrams display the overlap of scans from which CSMs are
derived by the three algorithms, corresponding to correct (left)
and incorrect (right) crosslinks. Out of 682 spectra that are
matched to correct crosslinks by at least 1 search engine in the
first technical repeat, 275 are matched by all 3, and almost all the
spectra (639) are matched by pLink. Out of 45 scans that are
matched with incorrect crosslinks by at least one algorithm, 27
are matched by pLink. One scan is matched to the same, incorrect
crosslink by all three algorithms. Upon manual inspection of the
spectrum, we found that the incorrect isotope peak is assigned to
the mass of the precursor by the mass spectrometer.
The number of correct and incorrect unique crosslinks
identified by the three algorithms at an estimated 5% CSM-FDR
are shown in Fig. 2c. In the case of all algorithms, the calculated
FDR of the unique crosslinks is higher than that of the CSMs.
While the calculated FDR of the CSMs identified by pLink is 4.3%,
this is propagated to 11.3% in the case of the unique crosslinks.
This is due to CSM redundancy. For the correct crosslinks there is
an average of 2.9 CSMs per crosslink. For the incorrect crosslinks,
this ratio is 1.0. This effect is similar for StavroX and Xi that have
CSM redundancies of 2.4 and 2.7, respectively. Out of 221
crosslinks that are identified by at least 1 search engine in the first
technical repeat, 217 are identified by pLink, 179 are identified by
Xi and 159 are identified by StavroX (Fig. 2d).
The number of CSMs and crosslinks identified when the results
are filtered to an estimated CSM-FDR of 1% are shown in
Supplementary Fig. 1, and values given in Supplementary Tables 4
and 5. Calculated FDR values of the unique crosslinks are 6.6%,
1.1% and 1.6% for pLink, StavroX and Xi, respectively, with pLink
identifying 207 correct crosslinks, StavroX identifying 102 and Xi
identifying 152.
Effect of validation strategies on crosslink results. The effect of
different validation methods on the sensitivity and accuracy of
crosslink assignment is shown in Fig. 3. In all cases, the results were
filtered to an estimated FDR of 5%, and the calculated FDR is
reported in terms of unique crosslinks. We started by validating
Kojak results with different tools, namely PeptideProphet19 and
Percolator18 (Fig. 3a), since Kojak has no built-in validation
method. We observed that PeptideProphet, which estimates FDR at
the CSM level, is a very stringent validation method that has a
calculated FDR of 2.4%, and that sensitivity is very low compared to
other algorithms; only 123 correct crosslinks were identified. Per-
colator was used for validation by considering the CSM-FDR, or by
considering only the highest-scoring CSM for each species (unique
CSM-FDR). Both methods allow a much higher degree of sensi-
tivity, but this comes with the price of much lower precision. When
results are filtered at the CSM-FDR level, 224 correct crosslinks
were identified, which is the highest of all identification approaches,
but with a highly elevated calculated FDR of 32%. At the unique
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Fig. 1 Design of the crosslinked peptide library. a the N-terminal amine
group is protected from crosslinking with a biotin group that is followed by
a linker region with a tryptic cleavage site. C-terminal lysine residues are
incorporated with an azide group to prevent crosslinking to this site.
b Peptides are crosslinked, treated with trypsin and the azide groups on
the C-terminal lysine residues are reduced to an amine. Biotin-linker
groups are removed from the solution with streptavidin beads. c The
synthetic peptides are crosslinked in separate groups and combined prior
to LC-MS analysis.
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CSM-FDR, 221 correct crosslinks were identified with a slightly
lower calculated FDR of 23%.
Fischer et al.9 report that FDRs can be estimated at different
points during data analysis, and it is implemented into Xi that the
FDR can be calculated on different levels. We compared FDR
estimations calculated at the CSM-FDR level, the unique CSM-
FDR level and the peptide pair-FDR level (Fig. 3b). We note a
slight decrease in the number of crosslinks identified when the
FDR calculation is performed later in the analysis (180, 174 and
160), along with a decrease in calculated FDR (5.4%, 4.8% and
3.2%) for the CSM level, unique CSM level and peptide pair level,
respectively. The distribution of scores attributed to target and
decoy sequences by Xi during FDR calculations at different levels
can be found in Supplementary Fig. 2.
StavroX offers two possibilities for generating the decoy
database: to shuffle sequences and keep protease sites or to invert
the sequences. Crosslink validation with an inverted sequence is
much more stringent than with the ‘shuffled sequence/ same
protease sites’ option. While 163 crosslinks are found with the
former (calculated FDR 5.2%), just 80 crosslinks are identified
with the latter, with a calculated FDR of 1.7% which is much lower
than the estimated CSM-FDR of 5%.
We were also interested to see how the various search
algorithms perform when the data are searched against a larger
database (Supplementary Fig. 3, Supplementary Table 7). For this
we used a database containing the sequence of S. pyogenes Cas9
and 116 contaminant proteins (the crapome27). For pLink and
the Kojak/Percolator combination, the larger database allowed a
more accurate CSM-FDR estimation, along with a slight
reduction in the number of correct crosslinks being identified.
For pLink the calculated FDR is reduced from 11.3% to 6.1% and
the number of correct crosslinks is reduced from 217 to 204,
while for Kojak/Percolator the calculated FDR when estimated at
the CSM level is reduced from 23% to 12% with a reduction in
correct crosslinks from 221 to 202. Interestingly, searching
against the larger database resulted in more crosslinks being
identified with Xi (e.g. from 160 to 175 for the peptide pair level)
along with an increase in calculated FDR (e.g. 3.2% to 6.7% for
the peptide pair level). For the Kojak/PeptideProphet combina-
tion, the larger database increases the FDR (2.4–3.7%) while
reducing the number of correctly identified crosslinks (123–121),
both of which are undesirable effects in a crosslinking study.
Comparison of scores attributed to CSMs. Another possible
reason for the discrepancy between algorithms is the scoring
functions. To investigate this further, scores attributed to CSMs
by the various algorithms are compared (Fig. 4). pLink scores
given to each CSM are compared with those given by Xi (Fig. 4a),
StavroX (Fig. 4b) and Kojak (Fig. 4d), and scores given by Xi are
compared to those given by StavroX (Fig. 4c). CSMs correlating
to correct crosslinks are shown in black, and CSMs correlating to
false positives are shown in red. The scores attributed by pLink to
false-positive identifications are at the lower end of the scoring
scale, suggesting that the pLink scoring system is robust. It is
therefore expected that a slightly more stringent scoring approach
would remove the false positives with little effect on the true
crosslinks. There is positive correlation between the scores of
pLink and Xi (R2= 0.41) and the scores of StavroX and Xi (R2=
0.44), with lower correlation between pLink and StavroX (R2=
0.15) and even lower between pLink and Kojak (R2= 0.06). This
demonstrates that all algorithms have very different approaches
for scoring crosslink assignments.
Score distributions for candidate and decoy CSMs. The score
distributions for the candidate and decoy peptides are shown
for pLink (Fig. 5a), Xi (Fig. 5b) and StavroX (Fig. 5c). The
distribution of the scores given to decoy crosslinks correlates well
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Fig. 2 Comparison of pLink, StavroX and Xi performance based on the crosslinked peptide library. a number of CSMs that correspond to correct (black)
and incorrect (grey) crosslinks identified by three search algorithms with incorporated FDR estimation. Results were filtered to an estimated 5% CSM-FDR,
and the calculated FDR is given for each algorithm. b Agreement of correct (left) and incorrect CSMs (right) between pLink, StavroX and Xi for one
technical repeat. c Number of correct unique crosslinks (black) and incorrect crosslinks (grey) identified with an estimated CSM-FDR of 5%. d Overlap of
correct (left) and incorrect crosslinks (right) for one technical repeat. Values for figures a and c are given in Supplementary Tables 2 and 3, and average
values ± standard deviation are shown on the stacked bar plots (rounded to the closest whole number). All results files can be found in Supplementary
Data 1. Error bars correspond to the standard deviation between technical replicates (n= 3).
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with the stringency and accuracy of the algorithms. pLink attri-
butes very low scores to the decoy crosslinks, and the score cut-off
for the candidate crosslinks is therefore very low. StavroX on the
other hand attributes a range of scores to decoy peptides, and the
cut-off value for candidate crosslinks is very high, providing a
stringent validation. For Xi, the situation lies between the two
extremes; the number of correct and incorrect crosslinks lies
between the number found for pLink and StavroX.
Number of MS2 spectra utilised by the search engines. During
measurement of the first technical replicate of the DSS-
crosslinked peptides, 5022 MS2 spectra were triggered during
the MS acquisition. In the case of pLink, 666 of these were
assigned to crosslinks, 172 were assigned to monolinks, looplinks
and unmodified peptides, 168 were assigned to candidate cross-
links that had a score below the cut-off for the estimated 5%
CSM-FDR, 383 were assigned to decoy PSMs (corresponding to
all species) and 3633 triggered spectra were not utilised in the
search (Fig. 6). From the 168 spectra that had a score below the
cut-off value for 5% CSM-FDR, just 4 additional correct cross-
links were identified that failed to pass the validation. An addi-
tional 105 incorrect crosslinks were found in this ‘unvalidated’
portion of the CSMs, demonstrating efficient separation of
crosslinks that are correctly and incorrectly assigned.
StavroX does not provide information on unmodified peptides
or the spectra that were assigned to decoy crosslinks. Never-
theless, a much higher number of spectra were assigned to
unvalidated species that had a score below the cut-off for an
estimated 5% CSM-FDR than pLink. From these, an additional 58
correct crosslinks were identified, and 389 incorrect. This suggests
that StavroX does not have a problem with identifying crosslinks,
but rather has difficulty distinguishing those that are correct from
those that are incorrect.
Xi ascribes 2677 spectra to decoy species, much higher than
pLink (383), which is a potential reason for it being a more
stringent search algorithm. Eleven additional correct crosslinks
can be identified in the ‘non-validated’ CSMs, which is a much
lower number than for StavroX, while 757 additional incorrect
crosslinks are identified, which is more than both StavroX and
pLink. Xi therefore appears to have a robust method of separating
correct crosslinks from incorrect.
Assessment of workflows developed for cleavable crosslinkers.
Recently, MS-cleavable crosslinkers have been developed to
increase confidence of crosslink assignments and to allow iden-
tification of crosslinks in more complex samples. Here, the pep-
tides were crosslinked as before with DSBU or DSSO and
measured using stepped HCD on an Orbitrap Q-Exactive HF-X
(Fig. 7). Data are searched against a database containing the
sequence of S. pyogenes Cas9 and the crapome27 with MeroX 2.0
(in Rise and RiseUP mode)28 and XlinkX in Proteome Discoverer
2.3 (ref. 29). This larger database was used for analysis of peptides
crosslinked with the cleavable reagents compared to DSS, because
a key benefit of such crosslinkers is the ability to search data
against larger databases, up to the scale of the human proteome.
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Fig. 3 Effect of crosslink validation strategies on overall results. a Kojak
results were validated by PeptideProphet or Percolator with which all CSMs
were used, or only the top-scoring CSM for each species. b Xi results were
validated at the CSM-FDR level, the unique CSM-FDR level or at the peptide
pair-FDR level. c StavroX results were validated against a decoy database in
which the sequences were shuffled with the protease sites remaining
unchanged, or in which the sequences were inverted. All values are
provided in Supplementary Table 6, and the average values ± standard
deviation are shown on the stacked box plots. All results files can be found
in Supplementary Data 1. Error bars correspond to the standard deviation
between technical replicates (n= 3).
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Also, it has been recommended by the developers to use a
database with at least 100 other protein sequences that are used as
support for FDR control29.
We first analysed data recorded on a Q-Exactive HFX with a
stepped HCD fragmentation method as recommended by
Iacobucci et al.28. Data were filtered to an estimated CSM-FDR
of 5% with no additional score cut-off values. When data from the
measurement of DSBU peptides are analysed by MeroX in Rise
mode (Fig. 7a), in which three out of four reporter peaks must be
present in the MS2 spectrum, 223 correct crosslinks and 12
incorrect crosslinks are identified, giving rise to a calculated FDR
of 4.9%. When used in RiseUP mode, which appears to be a less
stringent analysis method, the number of correct crosslinks
increases to 254 but the number of false identifications also rises to
23 resulting in an increased calculated FDR of 8.3%. XlinkX finds
120 correct crosslinks and 96 false positives, resulting in a
calculated FDR of 44%. One reason that fewer crosslinks are
detected with XlinkX is that, unlike MeroX, it does not report
crosslinks between two peptides of the same sequence. When such
crosslinks are removed from the MeroX search results, the
number of correctly identified crosslinks are 169 and 199 for Rise
and RiseUP mode, respectively. MeroX identifies a lower number
of DSSO-crosslinked peptides than DSBU, likely because MeroX
was developed for the analysis of DSBU-crosslinked samples. In
Rise mode 140 true crosslinks are identified (with 1 false positive,
calculated FDR 0.7%), and in RiseUP mode 162 true crosslinks are
identified (153 false positives, calculated FDR 49%). XlinkX
identifies 128 true DSSO crosslinks (with 62 false positives,
calculated FDR 33%), which is 8 more than were identified with
DSBU. When the estimated CSM-FDR cut-off was reduced to 1%,
the calculated FDR for the DSBU/Rise combination actually
increased to 5%, the DSBU/Riseup combination reduced to 5.9%
and the DSBU/XlinkX combination reduced to 24%. For the
DSSO-crosslinked peptides the calculated FDR is reduced to 0.8%
for Rise, 11% for Riseup and 29% for XlinkX. We were surprised
to note from this study that the estimated FDR is often less reliable
for cleavable crosslinkers than can be achieved with DSS (Fig. 2).
Methods involving MS3 and ETD that were developed for the
measurement of DSSO-crosslinked peptides on an Orbitrap
Fusion Lumos were also investigated, and the data were analysed
using XlinkX (Fig. 7c). Here, we also employed the recommended
score cut-off of 45 and minimum score difference of 4 (ref. 29).
Upon measurement with CID-ETD, 141 crosslinks were
identified, all of which were correct. MS2–MS3 measurements
allowed identification of 150 correct and 10 incorrect crosslinks,
resulting in a calculated FDR of 6.2%. The hybrid method MS2-
EThcD-MS3 gives rise to 156 correct and 8 incorrect crosslinks
(calculated FDR 4.9%). Measurement with stepped HCD gives
rise to the highest number of true crosslinks (172) with just one
false positive (0.5% calculated FDR).
Discussion
This unique synthetic crosslinked peptide library is an excellent
resource for the crosslinking community. The data arising from
analysis of the crosslinked peptides can be used for in-depth
assessment of the many algorithms available for XL identification.
This provides valuable information for users of XL-MS regarding
the performance of crosslink search algorithms, allowing them to
select data analysis strategies that meet their needs in terms of
confidence and sensitivity of crosslink assignments. The data will
also be invaluable in the development of crosslink search engines,
since it is known which crosslinks can be true, and which are
falsely identified. This allows better assessment of different FDR
calculations that are currently available.
This study also allows assertions to be made about the analysis
of crosslinking data. Eminently, when using pLink, or the Kojak/
Percolator combination, a large database is required for better
FDR estimation. A reason for better performance with the larger
database could be the higher number of CSMs in the resulting set
that increase the training size for the algorithm, or it could be that
false CSMs are less likely to be randomly assigned to Cas9,
thereby producing a more defined decoy population exploited by
the algorithms during the training regimen. This is particularly
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likely to be true for Percolator that performs best when trained on
100,000 or more spectra18, which is far more than the 5022
contained in this dataset. Alternatively, in our study, Xi and
Kojak/PeptideProphet perform better with a smaller database, for
example with 10 proteins. The data included in this publication
can be utilised to further optimise such parameters.
Additionally, when using XlinkX for the analysis of data in
which cleavable crosslinkers were used, the score cut-offs are
important in filtering for high-quality data that more likely allow
correct crosslink identification. One should be aware that while
such cut-offs work well in this study and others30,31, they give no
indication of the confidence in crosslink assignment. Judging by
the data, different cut-off values could be optimised for different
fragmentation techniques. For example, a lower value of 20 could
be used for the stHCD data that gives rise to 183 correct crosslinks
(11 more than with a score cut-off of 40) and 8 incorrect, resulting
in a calculated FDR of 4.1%. A similar approach was taken by Ser
et al.5 by spiking crosslinked BSA peptides into non-crosslinked
proteome background peptides to calculated score filters that
removed 99% and 90% of non-BSA crosslinks to determine FDR
cut-offs for 1% and 10% FDR, respectively. The data included in
the present publication could be even more useful for a systematic
optimisation of search and validation strategies.
Results from XL-MS studies have far-reaching implications,
often leading to new avenues of research regarding novel
protein–protein interactions. It is therefore of paramount
importance that the confidence of identified crosslinks is correctly
estimated. As well as providing a useful bioinformatics resource,
the physical library can be used to optimise many stages of the
crosslinking workflow including crosslink enrichment strategies,
chromatography methods and MS data acquisition parameters.
Methods
Peptide design and synthesis. Peptides were synthesised on a SYRO with Tip
Synthesis Module (MultiSynTech GmbH) using standard Fmoc chemistry. For
each amino acid cycle, double coupling with DIC/K-Oxyma and HATU/DIEA was
performed. C-terminal lysine residues were initially incorporated with an azide
group. Peptides were purified on a C18 kinetex column (2.6 µm) using a 30 min
gradient, and the identity of the peptides was confirmed using MALDI-MS (4800
MALDI TOF/TOF, Applied Biosystems). Peptide concentration was measured
using a nanodrop, the solution was evaporated to almost dryness, and the peptides
were resuspended at a concentration of 5 mM in HEPES buffer (100 mM pH 8) and
the appropriate peptides were combined into groups (Supplementary Table 1).
Crosslinking. Crosslinker was dissolved at 20mM in DMSO, and 0.5 µl were added
to 5 µl to each peptide group 5× over the course of 2.5 h. One microliter of each
crosslinked peptide group was added to 9 µl ammonium bicarbonate (ABC, 100mM)
for overnight digestion with 10 ng trypsin at 37 °C and subsequent reduction with tris
(2-carboxyethyl)phosphine for 30min (final concentration 50mM). All 12 groups
were combined into one sample which was stored at −80 °C in 5 µl aliquots for
future use.
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Biotin removal. After digestion, the biotin-linker region was removed with
streptavidin beads. Twenty-five microliters of slurry was washed three times with
25 µl ABC buffer. In all, 5 µl peptides+ 20 µl ABC buffer was loaded onto the
beads and incubated for 30 min. The eluate was removed and the beads were
washed with 25 µl 0.1% FA and subsequently 25 µl 30% MeOH. The eluates were
combined and reduced to 5 µl in a centrifugal concentrator to remove the
MeOH. The sample was then diluted 5× in 0.1% TFA and 1 µl of the final
solution was injected.
Reversed-phase high-performance liquid chromatography. Crosslinked pep-
tides were separated using a Dionex UltiMate 3000 high-performance liquid
chromatography (HPLC) RSLCnano System prior to MS analysis. The HPLC was
interfaced with the mass spectrometer via a Nanospray Flex ion source. For sample
concentrating, washing and desalting, the peptides were trapped on an Acclaim
PepMap C-18 precolumn (0.3 × 5 mm, Thermo Fisher Scientific) using a flow rate
of 25 μL/min and 100% buffer A (99.9% H2O, 0.1% TFA). The separation was
performed on an Acclaim PepMap C-18 column (50 cm × 75 μm, 2 μm particles,
100 Å pore size, Thermo Fisher Scientific) applying a flow rate of 230 nL/min. For
separation, a solvent gradient ranging from 2% to 40% buffer B (80% ACN, 19.92%
H2O, 0.08% TFA) was applied. The gradient length was 2 h for the analysis of the
combined groups.
Mass spectrometry. MS settings were used according to previously published
protocols. DSSO- and DSBU-crosslinked peptides were measured on both an
Orbitrap Q-Exactive HF-X instrument and an Orbitrap Fusion Lumos mass
spectrometer. DSS samples were measured on an Orbitrap Q-Exactive HF-X
instrument with the settings recommended by Chen and Rappsilber16 (MS1
Orbitrap resolution 120K, MS1 m/z scan range 400–1600, MS1 maximum injection
time 20 ms, MS1 AGC target 2e5, dynamic exclusion 30 s with 10ppm mass
window, minimum precursor intensity 5e4, charge state exclusion <3+ or >8+,
isolation window 2m/z, normalised collision energy 28, TopN N= 10 starting with
the most intense MS1 signal, MS2 resolution 35 K, MS2 maximum injection time
60 ms, MS2 AGC target 1e5) DSBU measurements on the HFX were measured
with the settings recommended by Iacobucci et al.28. (MS1 orbitrap resolution
140K, MS1 m/z scan range 300–1700, MS1 maximum injection time 100 ms, MS1
AGC target 3e6, dynamic exclusion 60 s with 2 ppm mass window, charge state
exclusion <3+ or >8+, isolation window 2m/z, stepped HCD with normalised
collision energies 27%, 30% and 33%, TopN N= 10 starting with the most intense
MS1 signal, MS2 resolution 17.5K, MS2 maximum injection time 250 ms, MS2
AGC target 2e5). DSSO samples were measured on an Orbitrap Fusion Lumos
mass spectrometer with the settings recommended by Klykov et al.29 for MS3 and
ETD-based acquisitions (MS1 orbitrap resolution 60K, MS1 m/z scan range
375–1500, MS1 AGC target 4e5, MS1 maximum injection time 50 ms, charge state
exclusion <3+ or >8+, dynamic exclusion 30 s with 10 ppm mass window. MS2-
CID: CID collision energy 30%, MS2 resolution 30K, AGC target 5e4, maximum
ion injection time 100 ms. MS2-ETD: MS2 resolution 30K, AGC target 1e5,
maximum ion injection time 120 ms. MS3: MS2 isolation window 2m/z, collision
energy 35%, AGC target 3e4, maximum ion injection time 90 ms). Settings
recommended by Stieger et al.32 were used for stepped HCD methods (MS1
orbitrap resolution 60K, MS1 m/z scan range 375–1500, MS1 maximum injection
time 50 ms, MS1 AGC target 5e5, dynamic exclusion 30 s with 10 ppm mass
window, charge state exclusion <3+ or >8+, isolation window 1.6m/z, stepped
HCD with normalised collision energies 21%, 27% and 33%, TopN N= 10 starting
with the most intense MS1 signal, MS2 resolution 30K, MS2 maximum injection
time 100 ms, MS2 AGC target 5e4).
Data analysis. Raw data collected from the measurement of DSS-crosslinked
peptides were converted to.mgf format using MSconvert with the Peak Picking
function and searched with the relevant programmes (pLink 2.3.5, StavroX 3.6.0, Xi
1.6.751, kojak 1.6.1) against a database containing S. pyogenes Cas9 and 10 addi-
tional proteins (Supplementary Data 2). Settings for each programme are given in
Supplementary Table 11. Data collected from the measurement of cleavable
crosslinkers were searched with MeroX 2.0 beta 5 and XlinkX in proteome dis-
coverer 2.3 against a database containing S. pyogenes Cas9 and the Crapome27.
Settings are given in Supplementary Information Table 12, and all search outputs
are provided in Supplementary Data 1.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Fig. 7 Assessment of algorithms for the identification of peptides
crosslinked with cleavable reagents DSBU and DSSO. a, b Data were
collected using MS2 method with stepped collision energy, analysed using
MeroX (in Rise and RiseUP mode) and XlinkX, with data filtered to an
estimated 5% FDR (a) and 1% FDR (b), with no additional score cut-off
values employed. c Data for DSSO-crosslinked peptides were collected
using HCD-, MS3- and ETD-based methods, and analysed using XlinkX
with the recommended score cut-off values of 45 and 4 for crosslink score
and Δcrosslink score, respectively. Values are given in Supplementary
Tables 8–10.
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Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE33 partner repository with the dataset identifier PXD014337.
All other data are available from the corresponding authors upon reasonable request.
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